Entering text into the input field will update the search result below

St. Jude Medical Q3 revenues up 12%, Non-GAAP EPS up 2%

  • St. Jude Medical (NYSE:STJ +2.3%) Q3 results: Revenues: $1,499M (+11.9%); Total U.S. Sales: $783M (+11.1%); Total International Sales: $716M (+12.9%); Operating Income: $286M (-2.7%); Net Income: $212M (-1.4%); EPS: $0.73 (-2.7%); Non-GAAP EPS: $0.99 (+2.1%); Quick Assets: $394M (-40.9%).
  • Q4 and FY16 Guidance: Due to the planned merger with Abbott, St. Jude Medical is withdrawing financial guidance for the fiscal year 2016.

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
STJ--
St. Jude Medical, Inc.